Investments
24Portfolio Exits
8Funds
3About Toucan Capital
Toucan Capital specializes in seed and early stage investments in novel, emerging technologies. We are particularly interested in working with inventors, researchers, scientists, and entrepreneurs at the very beginning of their efforts to commercialize an invention or technology. We look for emerging technologies with broad potential to create multiple products and multiple ways to win.
Want to inform investors similar to Toucan Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Toucan Capital Investments
24 Investments
Toucan Capital has made 24 investments. Their latest investment was in Inmune Bio as part of their Unattributed VC on July 7, 2017.
Toucan Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/13/2017 | Unattributed VC | Inmune Bio | $3.34M | Yes | 1 | |
11/7/2012 | Series E - II | Vital Therapies | $60M | No | 1 | |
9/28/2012 | Series E | Vital Therapies | $16M | No | ||
6/23/2011 | Series D | |||||
5/3/2011 | Series E |
Date | 7/13/2017 | 11/7/2012 | 9/28/2012 | 6/23/2011 | 5/3/2011 |
|---|---|---|---|---|---|
Round | Unattributed VC | Series E - II | Series E | Series D | Series E |
Company | Inmune Bio | Vital Therapies | Vital Therapies | ||
Amount | $3.34M | $60M | $16M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 1 | 1 |
Toucan Capital Portfolio Exits
8 Portfolio Exits
Toucan Capital has 8 portfolio exits. Their latest portfolio exit was Inmune Bio on February 04, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/4/2019 | IPO | Public | 3 | ||
Date | 2/4/2019 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 |
Toucan Capital Fund History
3 Fund Histories
Toucan Capital has 3 funds, including Toucan Capital Fund II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2002 | Toucan Capital Fund II LP | Early-Stage Venture Capital | Closed | $120M | 1 |
12/31/1998 | Toucan Capital Fund I LP | ||||
Toucan Capital Fund III LP |
Closing Date | 12/31/2002 | 12/31/1998 | |
|---|---|---|---|
Fund | Toucan Capital Fund II LP | Toucan Capital Fund I LP | Toucan Capital Fund III LP |
Fund Type | Early-Stage Venture Capital | ||
Status | Closed | ||
Amount | $120M | ||
Sources | 1 |
Toucan Capital Team
5 Team Members
Toucan Capital has 5 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Robert F. Hemphill | Founder | Current | |
Name | Robert F. Hemphill | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.